A Science and Technology Blog
With the alpha (B.1.1.7) and delta (B.1.617.2) variants widely present across the country, and the possibility of new variants with higher transmissive ability getting imported or emerging in India cannot…
By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people would become eligible to receive the vaccine and be fully…
Roping in the private sector to support the government programme of vaccinating about 270 million people belonging to the two high-risk priority groups can surely speed up vaccination coverage. At…
Those older than 45 years and with comorbidities will need a certificate from a registered medical doctor. But those older than 60 years will not need any certificate. only Serum Institute’s Covishield vaccine will be available at private hospitals. Self-registration needed for those above 45 years with comorbidities.
On January 3, the Indian regulator approved Covaxin for restricted use “under clinical trial mode” as a matter of “abundant caution” even when no interim data of phase-3 trial was…
On January 16, when the mass COVID-19 vaccination programme began in India, only 3,352 sessions were held and 0.19 million people were vaccinated. “The vaccination rate will increase exponentially in…
On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking the jab, only about two-third of the eligible people were…
